期刊文献+

盐酸环丙沙星胃漂浮缓释片的制备及体外释放 被引量:4

Preparation and in vitro Release of Ciprofloxacin Hydrochloride Floating Sustained-release Tablets
暂未订购
导出
摘要 以体外漂浮性能和释放度为指标优化盐酸环丙沙星胃漂浮缓释片的处方。结果表明,每片用量HPMC K100M为120mg、碳酸氢钠为200mg和羧甲淀粉钠为100mg的片剂能在1min内起漂,持续漂浮时间达8.2h,8h累积释放率达90%。按优化处方制备的片剂在高温(60℃)、强光(4500lx)下贮存10d,均保持稳定,高湿(相对温度75%)条件下有吸湿现象。 The formulation of ciprofloxacin hydrochloride intra-gastric floating sustained-release tablets was optimized with in vitro floating ability and release as indexes. The optimized tablets prepared with HPMC K100M 120mg, sodium bicarbonate 200mg and sodium carboxymethyl starch 100mg could float within lmin and maintain for 8.2h. The accumulative release of the drug for 8h was more than 90%. The tablets were stable under storage in 60℃ or 4500lx illumination intensity for 10d. The tablets were hydroscopic in the relative humidity 75 %.
作者 杨训 胡连栋
机构地区 河北大学药学院
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2007年第11期776-779,共4页 Chinese Journal of Pharmaceuticals
关键词 盐酸环丙沙星 胃漂浮缓释片 制备 体外释放 ciprofloxacin hydrochloride floating sustained-release tablet preparation in vitro release
  • 相关文献

参考文献4

二级参考文献11

  • 1董志超,蒋雪涛.羟丙基甲基纤维素的性质对药物亲水性骨架片溶出度的影响[J].药学学报,1994,29(12):920-924. 被引量:61
  • 2张辉文 吕文旭 等.恩丹西酮溶出度考察[J].西北药学杂志,1998,13(1):21-21.
  • 3Xu G Groves MJ.Effect of FITC-dextran mo1ecu1ar weight on its re1ease from f1oating cety1 a1coho1 and HPMC tab1ets [J].J Pharm Pharmaco1,2001,53(1):49-56.
  • 4Joseph A. Barone. Domperidone: Mechanism of action and clinical use[J].Hospital Pharmacy,1998,33(2):191-197.
  • 5Heykants J, Hendriks R, Meuldermans W,et al.On the pharma-cokinetics of domperidone in animals and man Ⅳ.The pharmacohinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral, and rectal administration[J]. European Journal of Drug Metabolism and Phamacokinetics,1981,6(1):61-70.
  • 6Joseph A. Barone.Domperidone: A peripherally acting dopamine2-receptor antagonist[J]. The Annals of Pharmacotherapy,1999,33:429-440.
  • 7Nagarsenker MS, Garad SD, Ramprakash G.Design, optimization and evaluation of domperidone coevaporates[J]. Journal of Controlled Release,2001,63:31-39.
  • 8吴伟,周全.胃内滞留漂浮型给药系统的研究概况与进展[J].国外医药(合成药.生化药.制剂分册),1998,19(2):123-128. 被引量:16
  • 9赵圣印.糖尿病治疗药的研究进展[J].国外医药(合成药.生化药.制剂分册),1999,20(3):130-135. 被引量:24
  • 10李龙芸,张力,崔朝勃,王孟昭,单渊东,密一英.恩丹西酮防治肿瘤化疗诱发的恶心及呕吐[J].中国新药杂志,2000,9(4):263-265. 被引量:3

共引文献50

同被引文献34

  • 1王锐利,张淑秋.胃漂浮片的研究进展[J].山西医科大学学报,2005,36(2):260-262. 被引量:23
  • 2侯惠民.新给药系统的工程化——新制剂及制造装置[J].中国医药工业杂志,2007,38(3):146-155. 被引量:5
  • 3ARORA S, ALI J, AHUJA A, et al. Floating drug delivery systems : a review [ J ]. AAPS Pharm Sci Tech, 2005,6 ( 3 ) : 372 - 390.
  • 4RAMJI A,CHANDRA G,PRABHAKAR V. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets [ J ]. AAPS Pharm Sci Tech, 2009,10 ( 1 ) : 220 - 226.
  • 5NARASAMHAN B. Molecular analysis of drug delivery controlled by dissolution of the polymer carrier[ J]. J Pharm Sci, 1997,3 (86) :297 -304.
  • 6WAN LSC ,HENG PWS,WONG LF. The effect of hydroxypropylmethylcellulose on water penetration into a matrix system [ J]. Int J Pharm,1991,73(2) :111 - 116.
  • 7MELIA CD, RAJABI-SIAHBOOMI AR, HODSDON AC,et al. Structure and behaviour of hydrophilic matrix sustained release dosage forms: 1. The origin and mechanism of formation of gas bubbles in the hydrated surface layer [ J ]. Int J Pharm, 1993, 100(1) :263 -269.
  • 8COLOMBO P,CATELLAN1 PL,PEPPAS NA,et al. Swelling characteristics of hydrophilic matrices for controlled release new dimesionless number to describe the swelling and release behavior [J]. lnt JPharm,1992,88(2):99-109.
  • 9沓仁芝,任君刚,金丽娜,吴高蕾.卡维地洛胃漂浮片的制备和体外释放[J].中国新药杂志,2007,16(19):1602-1605. 被引量:6
  • 10NEIY, LI Y X,ZHU S S. Effect of excipients on the floating properties of gastric floating drug dosage form [ J ]. 中南药学,2008,6(2):208-210.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部